Novartis (United States)

7.1k papers and 302.5k indexed citations i.

About

In recent decades, authors affiliated with Novartis (United States) have published 7.1k papers, which have received a total of 302.5k indexed citations. Scholars at this organization have produced 1.7k papers in Molecular Biology, 1.3k papers in Oncology and 1.1k papers in Pulmonary and Respiratory Medicine on the topics of Chronic Myeloid Leukemia Treatments (357 papers), Chronic Lymphocytic Leukemia Research (349 papers) and Advanced Breast Cancer Therapies (261 papers). Their work is cited by papers focused on Molecular Biology (94.9k citations), Oncology (54.6k citations) and Pulmonary and Respiratory Medicine (40.2k citations). Authors at Novartis (United States) collaborate with scholars in United States, Switzerland and United Kingdom and have published in prestigious journals including Nature, Science and Cell. Some of Novartis (United States)'s most productive authors include Abu T.M. Serajuddin, David J. Glass, Scott D. Solomon, Daseng Yang, Jeffrey S. Ross, Andrew J. Nichols, Glenn T. Barnes, Hong Chen, Haiyan Xu and Qing Yang.

In The Last Decade

Fields of papers published by authors at Novartis (United States)

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Novartis (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Novartis (United States) at the time of their publication.

Countries citing scholars working at Novartis (United States)

Since Specialization

Citations

This map shows the geographic impact of research produced by authors working at Novartis (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Novartis (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Novartis (United States) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Breakdown of academic impact, for scholars at Shanghai Institute of Ceramics Breakdown of academic impact, for scholars at Municipal Institute for Medical Research Breakdown of academic impact, for scholars at May Institute Breakdown of academic impact, for scholars at St. Mary's Hospital Breakdown of academic impact, for scholars at Joint Institute for Laboratory Astrophysics Breakdown of academic impact, for scholars at Spanish National Centre for Cardiovascular Research Breakdown of academic impact, for scholars at Perimeter Institute Breakdown of academic impact, for scholars at Microsoft Research Asia (China)